Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Ph…
Biotechnology
US, Burlingame [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Corvus Pharmaceuticals, Inc. has no acquisition track records yet.
M&A Deals · History
Corvus Pharmaceuticals, Inc. has no acquisition track records yet.